Lauren P. Silvernail
2015
In 2015, Lauren P. Silvernail earned a total compensation of $1.1M as Chief Financial Officer and Chief Business Officer at Revance Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,780 |
|---|---|
| Option Awards | $387,054 |
| Salary | $362,505 |
| Stock Awards | $118,317 |
| Other | $67,392 |
| Total | $1,086,048 |
Silvernail received $387.1K in option awards, accounting for 36% of the total pay in 2015.
Silvernail also received $150.8K in non-equity incentive plan, $362.5K in salary, $118.3K in stock awards and $67.4K in other compensation.
Rankings
In 2015, Lauren P. Silvernail's compensation ranked 7,551st out of 13,638 executives tracked by ExecPay. In other words, Silvernail earned more than 44.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,551 out of 13,638 | 45th |
Division Manufacturing | 2,855 out of 5,187 | 45th |
Major group Chemicals And Allied Products | 1,035 out of 1,857 | 44th |
Industry group Drugs | 833 out of 1,531 | 46th |
Industry Pharmaceutical Preparations | 651 out of 1,179 | 45th |
Source: SEC filing on March 24, 2017.
Silvernail's colleagues
We found two more compensation records of executives who worked with Lauren P. Silvernail at Revance Therapeutics in 2015.